A case of late distant recurrence/metastasis (≧10 years after curative surgery) of anaplastic lymphoma kinase-rearranged lung cancer and the review of similar cases in the literature

Q4 Medicine
Shohei Matsuo , Yoshitane Tsukamoto , Eiichiro Mabuchi , Shunichi Negoro , Seiichi Hirota
{"title":"A case of late distant recurrence/metastasis (≧10 years after curative surgery) of anaplastic lymphoma kinase-rearranged lung cancer and the review of similar cases in the literature","authors":"Shohei Matsuo ,&nbsp;Yoshitane Tsukamoto ,&nbsp;Eiichiro Mabuchi ,&nbsp;Shunichi Negoro ,&nbsp;Seiichi Hirota","doi":"10.1016/j.ehpc.2020.200421","DOIUrl":null,"url":null,"abstract":"<div><p>We experienced a 70-year-old female with brain and liver tumors. She underwent surgical operations for rectal cancer 8 year ago and lung cancer 16 years ago. Surgical removal of a brain tumor and a liver biopsy were performed. The brain tumor consisted of an adenocarcinoma with a solid signet-ring cell pattern. Under the possibility of metastatic anaplastic lymphoma kinase (ALK)-rearranged lung cancer in the brain and liver, immunohistochemistries (IHCs) for ALK were performed, returning positive results. Thus, metastasis of ALK-rearranged lung adenocarcinoma in the brain and liver had been confirmed. The patient was administered alectinib, which was well tolerated and has been in partial response for about one year and a half. By the genetic analyses for <em>EML4-ALK</em> variants, both the previous lung cancer and metastatic brain tumor were shown to harbor the same <em>EML4-ALK variant 3</em> fusion. We thus concluded that ALK-rearranged lung adenocarcinoma has recurred as liver and brain metastases 16 years after curative surgery.</p></div>","PeriodicalId":38075,"journal":{"name":"Human Pathology: Case Reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehpc.2020.200421","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Pathology: Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214330020300705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

We experienced a 70-year-old female with brain and liver tumors. She underwent surgical operations for rectal cancer 8 year ago and lung cancer 16 years ago. Surgical removal of a brain tumor and a liver biopsy were performed. The brain tumor consisted of an adenocarcinoma with a solid signet-ring cell pattern. Under the possibility of metastatic anaplastic lymphoma kinase (ALK)-rearranged lung cancer in the brain and liver, immunohistochemistries (IHCs) for ALK were performed, returning positive results. Thus, metastasis of ALK-rearranged lung adenocarcinoma in the brain and liver had been confirmed. The patient was administered alectinib, which was well tolerated and has been in partial response for about one year and a half. By the genetic analyses for EML4-ALK variants, both the previous lung cancer and metastatic brain tumor were shown to harbor the same EML4-ALK variant 3 fusion. We thus concluded that ALK-rearranged lung adenocarcinoma has recurred as liver and brain metastases 16 years after curative surgery.

间变性淋巴瘤激酶重排肺癌晚期远处复发/转移1例(术后10年以上)并文献复习
我们遇到了一位70岁的女性,她患有脑部和肝脏肿瘤。她在8年前接受了直肠癌手术,16年前接受了肺癌手术。手术切除了脑肿瘤并进行了肝脏活检。脑肿瘤是一种腺癌,具有坚实的印戒细胞模式。在脑和肝脏转移性间变性淋巴瘤激酶(ALK)重排肺癌的可能性下,对ALK进行免疫组织化学(IHCs)检测,结果为阳性。因此,alk重排肺腺癌在脑和肝的转移已被证实。患者给予阿勒替尼,该药耐受性良好,并已部分缓解约一年半。通过对EML4-ALK变异的遗传分析,先前的肺癌和转移性脑肿瘤都显示有相同的EML4-ALK变异3融合。因此,我们得出结论,alk重排肺腺癌在治愈手术16年后复发为肝和脑转移。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Pathology: Case Reports
Human Pathology: Case Reports Medicine-Pathology and Forensic Medicine
CiteScore
0.50
自引率
0.00%
发文量
0
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信